| HIV entry inhibitors: mechanisms of action and resistance pathways V Briz, E Poveda, V Soriano Journal of Antimicrobial Chemotherapy 57 (4), 619-627, 2006 | 300 | 2006 |
| Enfuvirtide, the first fusion inhibitor to treat HIV infection. E Poveda, V Briz, V Soriano AIDS reviews 7 (3), 139-147, 2005 | 151 | 2005 |
| HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors E Poveda, V Briz, M Quiñones-Mateu, V Soriano Aids 20 (10), 1359-1367, 2006 | 126 | 2006 |
| Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors E Poveda, C De Mendoza, L Martin-Carbonero, A Corral, V Briz, ... Journal of antimicrobial chemotherapy 60 (4), 885-888, 2007 | 71 | 2007 |
| Validation of a generation 4 phosphorus-containing polycationic dendrimer for gene delivery against HIV-1 V Briz, MJ Serramia, R Madrid, A Hameau, AM Caminade, JP Majoral, ... Current medicinal chemistry 19 (29), 5044-5051, 2012 | 62 | 2012 |
| Prevalence of X4 tropic HIV‐1 variants in patients with differences in disease stage and exposure to antiretroviral therapy E Poveda, V Briz, C de Mendoza, JM Benito, A Corral, N Zahonero, ... Journal of medical virology 79 (8), 1040-1046, 2007 | 54 | 2007 |
| Correlation between a phenotypic assay and three bioinformatic tools for determining HIV co-receptor use E Poveda, V Briz, V Roulet, M del Mar González, JL Faudon, K Skrabal, ... Aids 21 (11), 1487-1490, 2007 | 54 | 2007 |
| Raltegravir and etravirine are active against HIV type 1 group O V Briz, C Garrido, E Poveda, J Morello, P Barreiro, C de Mendoza, ... AIDS research and human retroviruses 25 (2), 225-227, 2009 | 52 | 2009 |
| Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 years V Briz, E Poveda, M del Mar González, L Martín-Carbonero, ... Journal of antimicrobial chemotherapy 61 (2), 405-410, 2008 | 38 | 2008 |
| Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicides V Briz, D Sepúlveda-Crespo, AR Diniz, P Borrego, B Rodes, ... Nanoscale 7 (35), 14669-14683, 2015 | 35 | 2015 |
| Etravirine‐based highly active antiretroviral therapy in HIV‐1‐infected paediatric patients V Briz, C Palladino, ML Navarro, S Jimenez de Ory, MI González‐Tomé, ... HIV medicine 12 (7), 442-446, 2011 | 33 | 2011 |
| Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitors E Poveda, F Blanco, P García-Gascó, A Alcolea, V Briz, V Soriano Aids 20 (11), 1558-1560, 2006 | 32 | 2006 |
| Persistent low-level viremia in persons living with HIV undertreatment: an unresolved status C Crespo-Bermejo, ER de Arellano, V Lara-Aguilar, D Valle-Millares, ... Virulence 12 (1), 2919-2931, 2021 | 31 | 2021 |
| Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents V Briz, JA León-Leal, C Palladino, D Moreno-Perez, SJ de Ory, ... The Pediatric infectious disease journal 31 (3), 273-277, 2012 | 31 | 2012 |
| Protist enteroparasites in wild boar (Sus scrofa ferus) and black Iberian pig (Sus scrofa domesticus) in southern Spain: a protective effect on hepatitis E acquisition? A Rivero-Juarez, A Dashti, P López-López, AS Muadica, MA Risalde, ... Parasites & Vectors 13, 1-9, 2020 | 30 | 2020 |
| Nanotechnology: A reality for diagnosis of HCV infectious disease S Arca-Lafuente, P Martinez-Roman, I Mate-Cano, R Madrid, V Briz Journal of Infection 80 (1), 8-15, 2020 | 30 | 2020 |
| Comparison of methods and characterization of small RNAs from plasma extracellular vesicles of HIV/HCV coinfected patients E Martínez-González, Ó Brochado-Kith, A Gómez-Sanz, ... Scientific Reports 10 (1), 11140, 2020 | 28 | 2020 |
| Epidemic history of hepatitis C virus genotypes and subtypes in Portugal C Palladino, IJ Ezeonwumelu, R Marcelino, V Briz, I Moranguinho, ... Scientific reports 8 (1), 12266, 2018 | 28 | 2018 |
| HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study MR López-Huertas, C Palladino, M Garrido-Arquero, B Esteban-Cartelle, ... Scientific reports 9 (1), 5606, 2019 | 27 | 2019 |
| Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique C Palladino, V Briz, JM Bellón, I Bartolo, P Carvalho, R Camacho, ... PLoS One 8 (12), e82718, 2013 | 27 | 2013 |
